Table 3 Antigen sensitivities and specificities. Table shows the IgG, IgM, and IgG + IgM sensitivities and specificities obtained using the vibrant microarray, and a comparison with the sensitivities and specificities of the current gold standard for respective pathogens.
Pathogen | IgM | IgG | IgM + IgG | |||||
---|---|---|---|---|---|---|---|---|
Sensitivity | Specificity | Sensitivity | Specificity | Sensitivity | Specificity | Sensitivity | Specificity | |
(%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | |
Borrelia burgdorferi | 60 | 100 | 94 | 100 | 100 | 100 | Early: | 95–100 |
77.6 | ||||||||
Late: | ||||||||
70–100 | ||||||||
Babesia microti | 79 | 98 | 91 | 97 | 99 | 96 | 70–80 | 94–100 |
Bartonella henselae | 81 | 99 | 96 | 99 | 100 | 98 | 100 | 96.8 |
Anaplasma phagocytophilum | 94 | 100 | 100 | 100 | 100 | 100 | 92 | 100 |
Ehrlichia chaffeensis | 84 | 100 | 100 | 99 | 100 | 99 | 83 | 100 |
Rickettsia typhi | 86 | 100 | 83 | 100 | 97 | 100 | 83–100 (IFA IgG) 53–100 (IFA IgM) | 91–100 (IFA IgG) 91–99 (IFA IgM) |
Rickettsia rickettsii | 43 | 99 | 71 | 99 | 86 | 98 | 85–100 (IFA IgG) 83–85 (IFA IgM) | 99–100 (IFA IgG) 100 (IFA IgM) |
Powassan virus | 100 | 100 | 100 | 100 | 100 | 100 | 89 | 65(IFA IgG), 100 (IgM IFA) |
Tickborne encephalitis | 78 | 99 | 92 | 99 | 93 | 98 | 83–94 (IgG) 94–100 (IgM) | 100 (IgM) 59–89 (IgG) |
West Nile virus | 25 | 100 | 80 | 100 | 85 | 100 | 100 | 70.3 |
Coxsackie virus | 56 | 100 | 100 | 100 | 100 | 100 | 94–97 | 100 |
Cytomegalovirus | 100 | 100 | 100 | 100 | 100 | 100 | 89.2 | 95 |
Epstein Barr virus VCA | 100 | 100 | 96 | 100 | 97 | 100 | 71 (VCA IgG), 95 (VCA IgM) | 99 |
Epstein Barr virus EBNA1 | 95 | 100 | 96 | 100 | 97 | 100 | 99 | 99 |
Parvovirus B19 | 90 | 99 | 98 | 98 | 99 | 97 | 92.7 | 100 |
Toxoplasma gondii | 100 | 99 | 100 | 100 | 100 | 99 | 94.2 (Both IgG and IgM) | 100 (both IgG and IgM) |
HSV-1 | 100 | 100 | 98 | 100 | 98 | 100 | 97–100 | 98 |
HSV-2 | 100 | 100 | 98 | 100 | 98 | 100 | 97–100 | 98 |
HHV-6 | 95 | 100 | 95 | 100 | 95 | 100 | 95 | 98.8 |